Français
ItalianoBond AbbVie 3.8% ( US00287YCX58 ) in USD
| Issuer | AbbVie | ||||||||
| Market price | 97.48 % ▲ | ||||||||
| Country |  United States
|
||||||||
| ISIN code |
 US00287YCX58 ( in USD )
|
||||||||
| Interest rate | 3.8% per year ( payment 2 times a year) | ||||||||
| Maturity | 15/03/2025 - Bond has expired | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | 2 000 USD | ||||||||
| Total amount | 2 889 199 000 USD | ||||||||
| Cusip | 00287YCX5 | ||||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||||
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YCX58, pays a coupon of 3.8% per year. The coupons are paid 2 times per year and the Bond maturity is 15/03/2025 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YCX58, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YCX58, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||